Announce Date | 04/23/2025 |
EPS Normalized Actual | $1.53 (Miss by $-0.04) |
EPS GAAP Actual | $1.53 (Miss by $-0.04) |
Revenue Actual | $0.496331B |
Revenue Surprise | Beat by $496.331M |
Announce Date | 07/01/2025 (Pre-Market) |
EPS Normalized Estimate | $1.70318 |
EPS GAAP Estimate | $1.70318 |
Revenue Estimate | $0.444576938B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 21.1874 | 2.37 | 20.13207 | 22.45786 | 2 |
Dec 2028 | 18.63476 | 2.7 | 17.23553 | 19.76531 | 3 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | 2.52 | 2.52 | 0.496331B | -6.34% | 496.33M |
FQ4 2024 (Dec 2024) | 1.06 | 1.06 | 0.468171B | 100% | 468.17M |
FQ3 2024 (Sep 2024) | 2.05 | 2.05 | 0.477155B | 6.37% | 477.16M |
FQ2 2024 (Jun 2024) | 1.44 | 1.44 | 0.429214B | 0.84% | 429.21M |
FQ1 2024 (Mar 2024) | 2.53 | 2.53 | 0.527788B | -5.84% | 527.79M |
FQ4 2023 (Dec 2023) | 0 | 0 | 0B | NAN% | 0M |
FQ3 2023 (Sep 2023) | 1.45 | 1.45 | 0.446754B | 100% | 446.75M |
FQ2 2023 (Jun 2023) | 1.97 | 1.97 | 0.425622B | 100% | 425.62M |
FQ4 Announce Date
07/01/2025 (Pre-Market)
Consensus EPS Estimates
1.70318
Consensus Revenue Estimates
0.444576938B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 3.62771 | -- | 3.51862 | 3.76855 | 1 |
FQ3 2027 (Sep 2027) | 3.13774 | -- | 3.04338 | 3.25956 | 1 |
FQ2 2027 (Jun 2027) | 1.51704 | -- | 1.47142 | 1.57594 | 1 |
FQ1 2027 (Mar 2027) | 3.44868 | -- | 3.34497 | 3.58257 | 1 |
FQ4 2026 (Oct 2026) | 4.80209 | -- | 4.45985 | 5.07911 | 1 |
FQ3 2026 (Jul 2026) | 2.35224 | -- | 2.1846 | 2.48794 | 1 |
FQ2 2026 (Jun 2026) | 1.82019 | -- | 1.70758 | 1.92816 | 1 |
FQ1 2026 (Mar 2026) | 4.44666 | 43.33 | 4.26041 | 4.72191 | 0 |
FQ4 2025 (Oct 2025) | 3.46492 | 69.41 | 3.21798 | 3.6648 | 2 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 0.52B | -- | 0.5B | 0.53B | 2 |
FQ3 2027 (Sep 2027) | 0.51B | -- | 0.49B | 0.52B | 2 |
FQ2 2027 (Jun 2027) | 0.43B | -- | 0.42B | 0.45B | 2 |
FQ1 2027 (Mar 2027) | 0.54B | -- | 0.53B | 0.56B | 2 |
FQ4 2026 (Oct 2026) | 0.6B | -- | 0.57B | 0.63B | 2 |
FQ3 2026 (Jul 2026) | 0.49B | -- | 0.46B | 0.51B | 2 |
FQ2 2026 (Jun 2026) | 0.37B | -- | 0.35B | 0.39B | 2 |
FQ1 2026 (Mar 2026) | 0.61B | 18.5 | 0.59B | 0.64B | 1 |
FQ4 2025 (Oct 2025) | 0.52B | 10.65 | 0.5B | 0.55B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
0
EPS # of in-lines
1
Revenue # of Beats
7
Revenue # of Misses
0
Revenue # of in-lines
1
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 2.52 | 2.52 | 100% | |
FQ4 2024 (Dec 2024) | 1.06 | 1.06 | 100% | |
FQ3 2024 (Sep 2024) | 2.05 | 2.05 | 100% | |
FQ2 2024 (Jun 2024) | 1.44 | 1.44 | 100% | |
FQ1 2024 (Mar 2024) | 2.53 | 2.53 | 100% | |
FQ4 2023 (Dec 2023) | 0 | 0 | NAN% | |
FQ3 2023 (Sep 2023) | 1.45 | 1.45 | 100% | |
FQ2 2023 (Jun 2023) | 1.97 | 1.97 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $0B | $0.5B | $496.33M | 100% |
FQ4 2024 (Dec 2024) | $0B | $0.47B | $468.17M | 100% |
FQ3 2024 (Sep 2024) | $0B | $0.48B | $477.16M | 100% |
FQ2 2024 (Jun 2024) | $0B | $0.43B | $429.21M | 100% |
FQ1 2024 (Mar 2024) | $0B | $0.53B | $527.79M | 100% |
FQ4 2023 (Dec 2023) | $0B | $0B | $0M | NAN% |
FQ3 2023 (Sep 2023) | $0B | $0.45B | $446.75M | 100% |
FQ2 2023 (Jun 2023) | $0B | $0.43B | $425.62M | 100% |